{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=2&page=5", "query": { "intervention": "2", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 79159, "total_pages": 7916, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=2&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=2&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T23:25:32.329Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03434119", "title": "Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Insulin glargine/Lixisenatide", "type": "DRUG" }, { "name": "Insulin glargine (HOE901)", "type": "DRUG" }, { "name": "Background therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 241, "start_date": "2018-02-20", "completion_date": "2019-01-07", "has_results": true, "last_update_posted_date": "2022-03-28", "last_synced_at": "2026-10-25T23:25:32.329Z", "location_count": 85, "location_summary": "Montgomery, Alabama • Little Rock, Arkansas • Anaheim, California + 63 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03434119" }, { "nct_id": "NCT00826865", "title": "Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Seizures" ], "interventions": [ { "name": "Levetiracetam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 27, "start_date": "2005-08", "completion_date": "2005-08", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-10-25T23:25:32.329Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00826865" }, { "nct_id": "NCT02098265", "title": "A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stroke" ], "interventions": [ { "name": "Functional Electric Stimulation (FES)", "type": "DEVICE" }, { "name": "Behavioral Assessments", "type": "BEHAVIORAL" }, { "name": "Magnetic Resonance Imaging", "type": "OTHER" }, { "name": "EEG", "type": "OTHER" }, { "name": "RecoveriX", "type": "OTHER" }, { "name": "Delay", "type": "OTHER" }, { "name": "BCI-FES", "type": "DEVICE" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL", "OTHER" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 288, "start_date": "2010-06", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-10-25T23:25:32.329Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02098265" }, { "nct_id": "NCT00033865", "title": "Yoga as a Treatment for Insomnia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Insomnia" ], "interventions": [ { "name": "Yoga, Relaxation Exercises, Sleep Hygiene", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "National Center for Complementary and Integrative Health (NCCIH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "25 Years to 59 Years" }, "enrollment_count": 48, "start_date": "2001-04", "completion_date": "2008-12", "has_results": false, "last_update_posted_date": "2015-04-28", "last_synced_at": "2026-10-25T23:25:32.329Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00033865" }, { "nct_id": "NCT01844700", "title": "1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "High Risk MC4R Genotype", "Low Risk MC4R Genotype", "One Week or Less Antipsychotic Lifetime Exposure" ], "interventions": [ { "name": "Ziprasidone", "type": "DRUG" }, { "name": "aripiprazole, quetiapine, or risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "13 Years to 18 Years" }, "enrollment_count": 14, "start_date": "2013-07", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2016-02-05", "last_synced_at": "2026-10-25T23:25:32.329Z", "location_count": 1, "location_summary": "Glen Oaks, New York", "locations": [ { "city": "Glen Oaks", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01844700" }, { "nct_id": "NCT02107300", "title": "NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Xerostomia" ], "interventions": [ { "name": "NeutraSal", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 32, "start_date": "2013-11", "completion_date": "2017-07-03", "has_results": true, "last_update_posted_date": "2018-12-11", "last_synced_at": "2026-10-25T23:25:32.329Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02107300" }, { "nct_id": "NCT00543569", "title": "A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kidney Transplantation" ], "interventions": [ { "name": "Alefacept", "type": "DRUG" }, { "name": "tacrolimus", "type": "DRUG" }, { "name": "basiliximab", "type": "DRUG" }, { "name": "mycophenolate mofetil", "type": "DRUG" }, { "name": "Corticosteroids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 323, "start_date": "2008-02", "completion_date": "2011-02", "has_results": true, "last_update_posted_date": "2015-12-11", "last_synced_at": "2026-10-25T23:25:32.329Z", "location_count": 38, "location_summary": "Loma Linda, California • Los Angeles, California • Sacramento, California + 28 more", "locations": [ { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00543569" }, { "nct_id": "NCT04872283", "title": "Effect of Postoperative Ketorolac on Bone Healing After Joint Fusion", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ketorolac", "Joint Fusion" ], "interventions": [ { "name": "great toe (1st metatarsophalangeal joint) fusion", "type": "PROCEDURE" }, { "name": "IV Ketorolac", "type": "DRUG" }, { "name": "Ketorolac Pill", "type": "DRUG" }, { "name": "5/325mg Oxycodone-Acetaminophen", "type": "DRUG" }, { "name": "Aspirin 81Mg Ec Tab", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Rothman Institute Orthopaedics", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2019-05-23", "completion_date": "2021-12-31", "has_results": false, "last_update_posted_date": "2021-05-04", "last_synced_at": "2026-10-25T23:25:32.329Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04872283" }, { "nct_id": "NCT02532283", "title": "A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza A Virus" ], "interventions": [ { "name": "JNJ-63623872", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Oseltamivir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 102, "start_date": "2015-12-11", "completion_date": "2017-03-15", "has_results": true, "last_update_posted_date": "2020-03-27", "last_synced_at": "2026-10-25T23:25:32.329Z", "location_count": 14, "location_summary": "Fresno, California • Long Beach, California • Stanford, California + 11 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Atlantis", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02532283" }, { "nct_id": "NCT00039741", "title": "Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT)", "type": "DRUG" }, { "name": "NNRTIs (EFV, NVP)", "type": "DRUG" }, { "name": "PIs (AMP, IDV, LPV/r, NFV, SQV, RTV)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Days", "maximum_age": "18 Years", "sex": "ALL", "summary": "30 Days to 18 Years" }, "enrollment_count": 266, "start_date": "2002-08", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2021-11-05", "last_synced_at": "2026-10-25T23:25:32.329Z", "location_count": 29, "location_summary": "Alhambra, California • Long Beach, California • Los Angeles, California + 22 more", "locations": [ { "city": "Alhambra", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00039741" } ] }